1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. INTERVENTIONAL CARDIOLOGY MARKET BY DEVICE TYPE
5.1. Introduction
5.2. Stents
5.2.1. Drug-Eluting Stents (DES)
5.2.2. Bare-Metal Stents (BMS)
5.2.3. Bioabsorbable Stents
5.3. Catheters
5.3.1. Diagnostic Catheters
5.3.2. Guiding Catheters
5.4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
5.4.1. Plain Old Balloon Angioplasty (POBA) Balloons
5.4.2. Cutting/Scoring Balloons
5.4.3. Drug-Coated Balloons (DCB)
5.5. Atherectomy Devices
5.6. Plaque Modification Devices
5.7. Guidewires
5.8. Embolic Protection Devices
5.9. Others
6. INTERVENTIONAL CARDIOLOGY MARKET BY APPLICATION
6.1. Introduction
6.2. Coronary Artery Disease
6.3. Heart Valve Disease
6.3.1. Transcatheter Aortic Valve Replacement (TAVR)
6.3.2. Transcatheter Mitral Valve Repair/Replacement (TMVR)
6.4. Peripheral Vascular Disease
6.5. Structural Heart Disease
6.5.1. Atrial Septal Defect (ASD) Closure
6.5.2. Patent Foramen Ovale (PFO) Closure
6.5.3. Left Atrial Appendage (LAA) Closure
6.6. Congenital Heart Defects
7. INTERVENTIONAL CARDIOLOGY MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Ambulatory Surgery Centers (ASCs)
7.4. Specialty Cardiac Centers
8. INTERVENTIONAL CARDIOLOGY MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Device Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Device Type
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Device Type
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Application
8.5.3. By Country
8.5.3.1. Saudi Arabia
8.5.3.2. UAE
8.5.3.3. Others
8.6. Asia Pacific
8.6.1. By Device Type
8.6.2. By Application
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic
10.2. Stryker
10.3. Abbott
10.4. B. Braun Melsungen AG
10.5. Boston Scientific Corporation
10.6. Cordis
10.7. Edwards Lifesciences Corporation
10.8. GE Healthcare
10.9. Biosensors International Group, Ltd.
10.10. Biotronik, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES